Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
29,948,325
-
Total 13F shares
-
5,218,628
-
Share change
-
+15,473
-
Total reported value
-
$72,689,568
-
Price per share
-
$13.93
-
Number of holders
-
78
-
Value change
-
+$181,766
-
Number of buys
-
40
-
Number of sells
-
27
Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q1 2023
As of 31 Mar 2023,
abrdn Life Sciences Investors - Common (HQL) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,218,628 shares.
The largest 10 holders included
MORGAN STANLEY, 1607 Capital Partners, LLC, FLAGSHIP HARBOR ADVISORS, LLC, RAYMOND JAMES & ASSOCIATES, WOLVERINE ASSET MANAGEMENT LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, Cornerstone Advisors, LLC, Allspring Global Investments Holdings, LLC, LAZARD ASSET MANAGEMENT LLC, and LPL Financial LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.